02Apr/13

Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI® – Financial Post

Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI®
Financial Post
Biogen Idec also has the deepest MS pipeline in the industry with compounds that include PLEGRIDY™ (peginterferon beta-1a); daclizumab high-yield process (DAC HYP) for monthly subcutaneous administration; and an ongoing study with TYSABRI as a

and more »

02Apr/13

Nelson Mandela's condition unchanged, no deterioration: Presidency – Times of India


Getty Images

Nelson Mandela’s condition unchanged, no deterioration: Presidency
Times of India
Asked about an NBC News report saying Mandela was still suffering a fluid build-up in his lungs, Maharaj said: “It is unfortunate that there are reports circulating in some media which suggest a deterioration, which is not true.” Mandela was admitted
Former South African prez Mandela still in hospitalZee News
Nelson Mandela spends ‘restful’ Easter in hospitalDaily News & Analysis
Mandela has family visitors in 5th day in hospitalKCAU
Newstrack India –India.Com Health –Outlook
all 275 news articles »
02Apr/13

To Your Health – SouthtownStar


Kilkenny People

To Your Health
SouthtownStar
As I sat down and prepared for the meeting, I received news that John had suffered a devastating complication and was in a coma that later progressed to brain death. One of our surgeons suggested that we approach his family about organ donation.
From the editor: I’m a donorLas Cruces Sun-News
KATHY VOCHOSKA: Save a life — sign up as an organ and tissue donorBakersfield Californian

all 48 news articles »

02Apr/13

Organ donation shortfalls in Ontario hospitals without transplant programs – GlobalNews.ca


GlobalNews.ca

Organ donation shortfalls in Ontario hospitals without transplant programs
GlobalNews.ca
determine whether a patient’s organs are donated or not: “the time pressure is substantial, because incidents often arise on weekends or at night when clinicians are short staffed, sleep deprived and uncertain about diagnosing brain death,” the
Organ donation shortfall at large general hospitals in OntarioEurekAlert (press release)

all 6 news articles »

02Apr/13

Patent Controversy Resumes as Indian Supreme Court Rejects Novartis' Glivec … – Knowledge Wharton Today


Knowledge Wharton Today

Patent Controversy Resumes as Indian Supreme Court Rejects Novartis’ Glivec
Knowledge Wharton Today
wars that have been fought in India over the past few years. By and large, multinationals have been losing out — for example, Hyderabad-based firm Natco Pharma was granted a compulsory license for Bayer’s liver and kidney anti-cancer drug Nexavar.
Why the rejection of Novartis patent plea is a huge victory for IndiaFirstpost
India court ruling could deprive developing nations of patented drugsRaw Story
Patent problemsBusiness Standard
Economic Times
all 458 news articles »